Close

Clinical Trials

Mural Health and China-based Clinflash Partner to Expand Global Patient Payment Solutions

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance, has today announced a strategic partnership with Clinflash, a leading provider of information...

Schreiner MediPharm’s Pharma-Comb IL Label Supports Innovative Clinical Cancer Trial Utilizing Oncolytic Viruses

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, is supplying its durable Pharma-Comb IL Label solution to a company whose clinical trial cancer medication requires low-temperature storage and pre-administration thawing, making marking and documentation particularly challenging. Various...

UCB, Veeva Partner to Advance Clinical Trial Efficiency

Veeva, a company involved in cloud software for the life sciences industry, and UCB, a global biopharmaceutical company, announced a collaboration that will focus on technology-driven solutions aimed at improving the patient experience and trial efficiency. UCB will adopt...

Preparing for the New Era: A Guide to Transitioning Clinical Trials to CTIS Regulation in the EU

As of January 31, 2022, the EU has implemented the Regulation 2014/536 on clinical trials for Medicinal Products (MPs) intended for human use. This regulation provides a centralized approach for electronic submission and evaluation of clinical trials. Alongside this,...

Why are decentralised clinical trials the future of the industry

Decentralized clinical trials (DCTs) can be considered to be the future of the industry due to the benefits they provide to drug developers and patients and their growing popularity. These benefits include ease for patients to participate in trials...

FDA Releases Draft Guidance On Decentralized Clinical Trials

US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials when it comes to drugs, biologics, and devices. The publication has in it recommendations from...

First of A Kind Gene Silencing Alzheimers Drug Shows Promise

UK scientists have gone on to conduct the first ever trial of a new drug for Alzheimer’s that is able to safely as well as successfully lower the levels of the very harmful tau protein, which is known to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read